RNF149 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.901000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.847800E-01
Normal-vs-Stage2
2.590800E-01
Normal-vs-Stage3
8.114400E-01
Normal-vs-Stage4
3.436200E-01
Stage1-vs-Stage2
1.235010E-01
Stage1-vs-Stage3
8.002000E-01
Stage1-vs-Stage4
4.867800E-01
Stage2-vs-Stage3
1.108610E-01
Stage2-vs-Stage4
6.386400E-01
Stage3-vs-Stage4
3.717600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.025400E-01
Normal-vs-AfricanAmerican
5.711600E-01
Normal-vs-Asian
4.399600E-01
Caucasian-vs-AfricanAmerican
5.282800E-01
Caucasian-vs-Asian
7.092200E-01
AfricanAmerican-vs-Asian
6.966400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.780200E-01
Normal-vs-Female
4.172000E-01
Male-vs-Female
5.340200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.469000E-01
Normal-vs-Age(41-60Yrs)
1.794770E-01
Normal-vs-Age(61-80Yrs)
5.162000E-01
Normal-vs-Age(81-100Yrs)
4.257800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.164400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.348400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.425000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.708410E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.783180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.680800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.504200E-01
Normal-vs-Daily Drinker
4.589800E-01
Normal-vs-Weekly Drinker
2.063000E-01
Normal-vs-Occasional Drinker
2.908400E-01
Normal-vs-Social Drinker
4.765400E-01
Non Drinker-vs-Daily Drinker
5.807400E-01
Non Drinker-vs-Weekly Drinker
3.796800E-01
Non Drinker-vs-Occasional Drinker
2.520800E-01
Non Drinker-vs-Social Drinker
9.592200E-01
Daily Drinker-vs-Weekly Drinker
7.793600E-01
Daily Drinker-vs-Occasional Drinker
5.995800E-01
Daily Drinker-vs-Social Drinker
6.667600E-01
Weekly Drinker-vs-Occasional Drinker
7.944000E-01
Weekly Drinker-vs-Social Drinker
4.105000E-01
Occasional Drinker-vs-Social Drinker
3.294000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.932200E-01
Normal-vs-Grade 2
3.018500E-02
Normal-vs-Grade 3
2.300200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.21919999990428E-07
Grade 1-vs-Grade 3
6.5626000000929E-07
Grade 1-vs-Grade 4
5.932200E-01
Grade 2-vs-Grade 3
3.674200E-01
Grade 2-vs-Grade 4
3.018500E-02
Grade 3-vs-Grade 4
2.300200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.809400E-01
Normal-vs-NonDiabetic
3.709800E-01
Diabetic-vs-NonDiabetic
6.746800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.220400E-01
Normal-vs-NoPancreatitis
4.311800E-01
Pancreatitis-vs-NoPancreatitis
3.945000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.736000E-01
Normal-vs-N1
2.765600E-01
N0-vs-N1
4.405700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.210000E-01
Normal-vs-TP53-NonMutant
4.515600E-01
TP53-Mutant-vs-TP53-NonMutant
3.35680039320607E-10
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
